Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 ends winning streak as pound rises, virus fears persist

Thu, 13th Feb 2020 08:58

* FTSE 100 down 1.1%, FTSE 250 down 0.6%

* Centrica, Barclays drag on main index

* Number of coronavirus cases in China rises

* Exporters hurt by a stronger pound
(Adds news items, analyst comments, closing prices)

By Shashwat Awasthi and Noor Zainab Hussain

Feb 13 (Reuters) - London's blue-chip index fell on Thursday
after two successive days of gains, dragged down by exporters
which were hurt by a stronger pound as investors positioned for
a higher-spending budget next month under a new British finance
minister.

The FTSE 100 ended the session 1.1% lower, derailed
by steep falls in heavyweights Barclays and Centrica
, while a rise in new coronavirus cases in China jolted
broader risk sentiment.

British utility Centrica skidded 15.3% after its 2019 profit
slumped by more than a third, while Barclays slipped 1.7% as
news Britain's financial regulators were probing historical
links between the bank's chief executive officer and U.S.
financier Jeffrey Epstein overshadowed financial results.

The mid-cap FSTE 250 lost 0.6%, tracking a broader
risk-off sentiment as the Chinese province of Hubei, an
epicentre of the coronavirus outbreak, reported a record rise in
deaths and thousands of more cases.

The increase in numbers, which came after China introduced a
new diagnostic procedure involving quicker computerised
tomography (CT) scans to screen patients, dented hopes that the
outbreak would soon plateau.

After the initial outbreak roiled global markets last month,
investors have become more sensitive to the rate of escalation.

"China is the world’s largest importer of oil so the renewed
fears about the health crisis have hit stocks like BP and Royal
Dutch Shell," CMC Markets analyst David Madden said, adding that
mining stocks such as BHP, Rio Tinto and Anglo
American were hurt too.

"It has been a double whammy for the FTSE 100 as the drive
higher in sterling has dented internationally focused stocks
like GlaxoSmithKline and AstraZeneca, plus
Unilever," he said.

The midcap index was also dragged down by British gambling
firms William Hill, GVC, Playtech and
888 following a media report that the gambling
commission would consider putting limits on the amount consumers
are allowed to bet online.

All sectors of the FTSE 100 ended lower, with oil majors
Shell and BP among the major drags, followed by
financials. The index substantially underperformed the broader
European benchmark as more of its components are
exposed to commodity prices.

UAE-based NMC Health, whose shares have swung
sharply in recent sessions amid takeover chatter, tumbled 4.2%
after analysts at SocGen slapped a double rating downgrade on
the stock.

Coca Cola HBC outperformed with a 3.6% gain after
it, along with fellow bottler Coca-Cola European Partners
, reported a higher annual profit.

Small-cap drugmaker Indivior fell more than 19%
after it reported a fourth-quarter loss.
(Reporting by Shashwat Awasthi in Bengaluru; Editing by Arun
Koyyur and Shounak Dasgupta and Kirsten Donovan)

More News
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.